Stuart Rich insider trades
Open-market stock purchases and sales by Stuart Rich, Chief Medical Officer at Tenax Therapeutics, Inc, from SEC Form 4 filings since Jan 15, 2021.
Track record: 0% of 5 scored buys are up 5% or more since purchase, averaging -80%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 9, 2026 | TENX Tenax Therapeutics, Inc | Bought (not open market) | — |
| Dec 9, 2025 | TENX Tenax Therapeutics, Inc | Bought | $25.5K |
| Dec 8, 2025 | TENX Tenax Therapeutics, Inc | Bought | $25.3K |
| Dec 4, 2025 | TENX Tenax Therapeutics, Inc | Bought | $23K |
| Dec 3, 2025 | TENX Tenax Therapeutics, Inc | Bought | $13.6K |
| Dec 2, 2025 | TENX Tenax Therapeutics, Inc | Bought | $9K |
Companies traded
- TENX Tenax Therapeutics, Inc: 5 buys, last Jan 9, 2026